TLR4/NF-κB通路与骨质疏松症关系的研究进展
Research progress in the relationship between TLR4/NF-κB pathway and osteoporosis
  
DOI:10.3969/j.issn.1006-7108.2023.07.020
中文关键词:  Toll样受体4  炎症  骨质疏松
英文关键词:toll-like receptor 4  inflammation  osteoporosis
基金项目:国家自然科学基金地区科学基金项目(82060895)
作者单位
程鉥泺1 陶雪芬1* 赵荣2,3* 吴柯楠2 贺明2 邢利威2 1.南京中医药大学附属南京市中西医结合医院针灸科江苏 南京 210000 2.云南中医药大学云南 昆明 650500 3.云南中医药大学第一临床医学院云南 昆明 650032 
摘要点击次数: 256
全文下载次数: 0
中文摘要:
      骨质疏松症(osteoporosis,OP)是一种普遍存在的与年龄相关的骨骼疾病,雌激素缺乏和衰老是主要病因,近年来越来越多的研究表明炎症反应在OP的发生发展过程中发挥重要作用。Toll样受体4(toll like receptor 4,TLR4)是Toll样受体家族的主要成员,是内毒素最重要的模式识别受体。TLR4是经典的炎症信号转导通路,当TLR4信号通路激活,与核因子κB (nuclear factor κB,NF-κB)转移到细胞核并释放炎性细胞因子(TNF-α、IL-1β、IL-6等),并抑制骨髓间充质干细胞成骨分化及钙盐沉积,促进破骨细胞成熟,最终导致OP。对TLR4信号通路与OP关系的研究不仅可以从炎症角度深入揭示OP的发病机制,还可以为OP的防治提供新的思路。
英文摘要:
      Osteoporosis (OP) is a common age-related bone disease caused primarily by oestrogen deficiency and aging. Recently, more evidences show that inflammatory activity plays an important role in the development of OP. Toll-like receptor 4 (TLR4) is a main member of toll-like receptor familay and a classical inflammatory signaling pathway. When it is activated, it translocates to the nucleus with nuclear factor B (NF-κB) and releases inflammatory cytokines (TNF-α, IL-1, IL-6, etc.), and inhibits osteogenic differentiation of bone marrow mesenchymal stem cells (MSCs) and calcium deposition, and stimulates the maturation of osteoclasts, leading to OP. The investigation of the relationship between the TLR4 signaling pathway and OP can provide not only the insight into the pathogenesis of OP from the standpoint of inflammation, but also new approaches for the prevention and treatment of OP.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=FC9DA7BF2F842A3BAE24B54F70914FE6BE46A02E5D59CB911219E8633EF89EC242FD3691287C07476543178B206232476259CDD451DDB624D8C6229105DB34C31DCC8E8ABB70D4CF4BC66DDE2F6D376174680B6DB57EFCF6&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=BA1E75DF0B7E0EB2&aid=&vid=&iid=DF92D298D3FF1E6E&sid=1F51A4E3D1D75885&eid=9E5DBB98644FDC52&fileno=202307020&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="BA1E75DF0B7E0EB2"; var my_aid="";